Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Asthma
- Cardiology
  - BACK
  - Cardiology
  - Hypercholesterolemia
  - Lp(a)
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - C3 Glomerulopathy
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

clinical topic updates

Maintenance Therapy Post Allogeneic Stem Cell Transplantation in High-Risk MDS and AML

Maintenance Therapy Post Allogeneic Stem Cell Transplantation in High-Risk MDS and AML

clinical topic updates
By Andrew M. Brunner, MD

Updates on TP53-Mutant AML and MDS With Excess Blasts

Updates on TP53-Mutant AML and MDS With Excess Blasts

clinical topic updates
By Andrew M. Brunner, MD

Bruton Tyrosine Kinase Inhibition in the Treatment of Mantle Cell Lymphoma

Bruton Tyrosine Kinase Inhibition in the Treatment of Mantle Cell Lymphoma

clinical topic updates
By Anita Kumar, MD

Chimeric Antigen Receptor T-cell Therapy in Relapsed Mantle Cell Lymphoma

Chimeric Antigen Receptor T-cell Therapy in Relapsed Mantle Cell Lymphoma

clinical topic updates
By Caron A. Jacobson, MD, MMSc

Evaluating Combined TIM-3 Inhibition and Hypomethylating Agent Therapy in High-Risk MDS and AML

Evaluating Combined TIM-3 Inhibition and Hypomethylating Agent Therapy in High-Risk MDS and AML

clinical topic updates
By Andrew M. Brunner, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?